Middle East & Africa Molecular Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)

No. of Pages: 120    |    Report Code: TIPRE00026716    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Molecular Diagnostics Market

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           Middle East & Africa Molecular Diagnostics Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1         Middle East & Africa PEST Analysis

5.           Middle East & Africa Molecular Diagnostics Market - Key Industry Dynamics

5.1       Key Market Drivers:

5.1.1         Development of New Products and Increase in Demand for Point-of-Care Testing

5.1.2         Surging Prevalence of Associated Diseases

5.2       Market Restraints

5.2.1         Limitations Associated with Molecular Testing

5.3       Market Opportunities

5.3.1         Advancements in Molecular Diagnostics Technologies

5.4       Future Trends

5.4.1         Molecular Diagnostics in Personalized Medicine

5.5       Impact Analysis:

6.           Molecular Diagnostics Market - Middle East & Africa Market Analysis

6.1       Middle East & Africa Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030

7.           Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area

7.1       Overview

7.2       Middle East & Africa Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)

7.3       Oncology

7.3.1         Overview

7.3.2         Oncology: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.4       Infectious Disease

7.4.1         Overview

7.4.2         Infectious Disease: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.5       Genetic Testing

7.5.1         Overview

7.5.2         Genetic Testing: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.6       Cardiac Diseases

7.6.1         Overview

7.6.2         Cardiac Diseases: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.7       Immune System Disorders

7.7.1         Overview

7.7.2         Immune System Disorders: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.8       Others

7.8.1         Overview

7.8.2         Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.           Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology

8.1       Overview

8.2       Middle East & Africa Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

8.3       Polymerase Chain Reaction

8.3.1         Overview

8.3.2         PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.2.1           RT-PCR

8.3.2.1.1          Overview

8.3.3         RT-PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.3.1           qPCR

8.3.3.1.1          Overview

8.3.4         qPCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.4.1           Multiplex PCR

8.3.4.1.1          Overview

8.3.5         Multiplex PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.5.1           Others

8.3.5.1.1          Overview

8.3.6         Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1         Overview

8.4.2         Isothermal Nucleic Acid Amplification Technology (INAAT): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.5       DNA Sequencing and Next-Generation Sequencing (NGS)

8.5.1         Overview

8.5.2         DNA Sequencing and Next-Generation Sequencing (NGS): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.6       DNA Microarrays

8.6.1         Overview

8.6.2         DNA Microarrays: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.7       In-Situ Hybridization (ISH)

8.7.1         Overview

8.7.2         In-Situ Hybridization (ISH): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.8       Others

8.8.1         Overview

8.8.2         Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.           Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services

9.1       Overview

9.2       Middle East & Africa Molecular Diagnostics Market Revenue Share, by Product and Services  2022 & 2030 (%)

9.3       Assays and Kits

9.3.1         Overview

9.3.2         Assays and Kits: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.4       Instruments

9.4.1         Overview

9.4.2         Instruments: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.5       Services and Software

9.5.1         Overview

9.5.2         Services and Software: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.        Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User

10.1     Overview

10.2     Middle East & Africa Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

10.3     Hospitals and Clinics

10.3.1       Overview

10.3.2       Hospitals and Clinics: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.4     Diagnostics Laboratories

10.4.1       Overview

10.4.2       Diagnostics Laboratories: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.5     Research and Academic Institutes

10.5.1       Overview

10.5.2       Research and Academic Institutes: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.6     Others

10.6.1       Overview

10.6.2       Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.        Middle East & Africa Molecular Diagnostics Market - Country Analysis

11.1     Middle East & Africa Molecular Diagnostics Market, Revenue and Forecast to 2030

11.1.1       Overview

11.1.1.1         Middle East & Africa Molecular Diagnostics Market by Country

11.1.2       UAE

11.1.2.1         Overview

11.1.3       UAE: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.4       UAE: Molecular Diagnostics Market, by Disease Area

11.1.5       UAE: Molecular Diagnostics Market, by Technology

11.1.5.1         UAE:  Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.6       UAE: Molecular Diagnostics Market, by Product and Services

11.1.7       UAE:  Molecular Diagnostics Market, by End User

11.1.8       Saudi Arabia

11.1.8.1         Overview

11.1.9       Saudi Arabia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.10    Saudi Arabia: Molecular Diagnostics Market, by Disease Area

11.1.11    Saudi Arabia: Molecular Diagnostics Market, by Technology

11.1.11.1      Saudi Arabia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.12    Saudi Arabia:  Molecular Diagnostics Market, by Product and Services

11.1.13    Saudi Arabia:  Molecular Diagnostics Market, by End User

11.1.14    South Africa

11.1.14.1      Overview

11.1.15    South Africa: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.16    South Africa: Molecular Diagnostics Market, by Disease Area

11.1.17    South Africa: Molecular Diagnostics Market, by Technology

11.1.17.1      South Africa: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.18    South Africa: Molecular Diagnostics Market, by Product and Services

11.1.19    South Africa: Molecular Diagnostics Market, by End User

11.1.20    Rest of Middle East & Africa

11.1.20.1      Overview

11.1.21    Rest of Middle East & Africa: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.22    Rest of Middle East & Africa:  Molecular Diagnostics Market, by Disease Area

11.1.23    Rest of Middle East & Africa:  Molecular Diagnostics Market, by Technology

11.1.23.1      Rest of Middle East & Africa: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.24    Rest of Middle East & Africa:  Molecular Diagnostics Market, by Product and Services

11.1.25    Rest of Middle East & Africa: Molecular Diagnostics Market, by End User

12.        Middle East & Africa Molecular Diagnostics Market Industry Landscape

12.1     Overview

12.2     Growth Strategies Done by the Companies in the Market (%)

12.3     Organic Developments

12.3.1       Overview

12.4     Inorganic Developments

12.4.1       Overview

13.        Middle East & Africa Molecular Diagnostics Market, Key Company Profiles

13.1     Abbott Laboratories

13.1.1       Key Facts

13.1.2       Business Description

13.1.3       Products and Services

13.1.4       Financial Overview

13.1.5       SWOT Analysis

13.1.6       Key Developments

13.2     Thermo Fisher Scientific Inc

13.2.1       Key Facts

13.2.2       Business Description

13.2.3       Products and Services

13.2.4       Financial Overview

13.2.5       SWOT Analysis

13.2.6       Key Developments

13.3     F. Hoffmann-La Roche Ltd

13.3.1       Key Facts

13.3.2       Business Description

13.3.3       Products and Services

13.3.4       Financial Overview

13.3.5       SWOT Analysis

13.3.6       Key Developments

13.4     Qiagen NV

13.4.1       Key Facts

13.4.2       Business Description

13.4.3       Products and Services

13.4.4       Financial Overview

13.4.5       SWOT Analysis

13.4.6       Key Developments

13.5     bioMerieux SA

13.5.1       Key Facts

13.5.2       Business Description

13.5.3       Products and Services

13.5.4       Financial Overview

13.5.5       SWOT Analysis

13.5.6       Key Developments

13.6     Illumina Inc

13.6.1       Key Facts

13.6.2       Business Description

13.6.3       Products and Services

13.6.4       Financial Overview

13.6.5       SWOT Analysis

13.6.6       Key Developments

13.7     Danaher

13.7.1       Key Facts

13.7.2       Business Description

13.7.3       Products and Services

13.7.4       Financial Overview

13.7.5       SWOT Analysis

13.7.6       Key Developments

13.8     Siemens Healthineers AG

13.8.1       Key Facts

13.8.2       Business Description

13.8.3       Products and Services

13.8.4       Financial Overview

13.8.5       SWOT Analysis

13.8.6       Key Developments

13.9     Novartis AG

13.9.1       Key Facts

13.9.2       Business Description

13.9.3       Products and Services

13.9.4       Financial Overview

13.9.5       SWOT Analysis

13.9.6       Key Developments

14.        Appendix

14.1     About Us

14.2     Glossary of Terms

 

List of Tables

Table 1.              Middle East & Africa Molecular Diagnostics Market Segmentation

Table 2.              UAE:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 3.              UAE:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 4.              UAE:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 5.              UAE:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 6.              UAE:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 7.              Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 8.              Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 9.              Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 10.           Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 11.           Saudi Arabia:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 12.           South Africa: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 13.           South Africa: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 14.           South Africa: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 15.           South Africa: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 16.           South Africa: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 17.           Rest of Middle East & Africa: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) –  Disease Area

Table 18.           Rest of Middle East & Africa:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 19.           Rest of Middle East & Africa:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 20.           Rest of Middle East & Africa:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 21.           Rest of Middle East & Africa:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 22.           Organic Developments Done By Companies

Table 23.           Inorganic Developments Done By Companies

Table 24.           Glossary of Terms, Molecular Diagnostics Market

 

 

List of Figures

Figure 1.            Middle East & Africa - PEST Analysis

Figure 2.            Middle East & Africa Molecular Diagnostics Market - Key Industry Dynamics

Figure 3.            Impact Analysis of Drivers and Restraints

Figure 4.            Middle East & Africa Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030

Figure 5.            Middle East & Africa Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)

Figure 6.            Oncology: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.            Infectious Disease: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.            Genetic Testing: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.            Cardiac Diseases: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10.          Immune System Disorders: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.          Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.          Middle East & Africa Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 13.          PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14.          RT-PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.          qPCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16.          Multiplex PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.          Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.          Isothermal Nucleic Acid Amplification Technology (INAAT): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19.          DNA Sequencing and Next-Generation Sequencing (NGS): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.          DNA microarrays: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.          In-Situ Hybridization (ISH): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.          Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.          Middle East & Africa Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

Figure 24.          Assays and Kits: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.          Instruments: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26.          Services and Software: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 27.          Middle East & Africa Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

Figure 28.          Hospitals and Clinics: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.          Ambulatory Surgical Centers: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.          Research and Academic Institutes: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.          Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.          Molecular Diagnostics Market, By Country, 2022 And 2030 ($Mn)

Figure 33.          Middle East & Africa Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)

Figure 34.          UAE:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 35.          Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 36.          South Africa: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 37.          Rest of Middle East & Africa:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 38.          Growth Strategies Done by the Companies in the Market (%)

The List of Companies - Middle East & Africa Molecular Diagnostics Market

  1. Abbott Laboratories
  2. bioMerieux SA
  3. Danaher
  4. F. Hoffmann-La Roche Ltd
  5. Illumina Inc
  6. Novartis AG
  7. Qiagen NV
  8. Siemens Healthineers AG
  9. Thermo Fisher Scientific Inc